The concept of spondyloarthritis: Where are we now?

Neha Garg, Filip Van Den Bosch, Atulya (Atul) Deodhar

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

The term spondyloarthritis (SpA) encompasses a group of diseases characterized by inflammation in the spine and in the peripheral joints, and other clinical features such as uveitis, dactylitis, psoriasis, inflammatory bowel disease, and association with human leukocyte antigen (HLA) B27. The spectrum of SpA encompasses axial spondyloarthritis (axSpA) and peripheral spondyloarthritis including psoriatic arthritis (PsA), reactive arthritis (ReA), and inflammatory bowel disease-associated arthritis. In recent years, there has been tremendous progress in understanding the natural history and pathogenetic mechanisms underlying SpA leading to the development of effective treatments. It has become imperative to identify the disease early, and accurately, to avail patients of effective treatments in a safe manner. The development of the Assessment of SpondyloArthritis International Society (ASAS) classification criteria has been a welcome advance in this regard. This article provides a historical evolution of the concept of SpA, from the Rome Criteria to the ASAS criteria, current issues and barriers with the use of ASAS criteria, and the work that still needs to be done moving forward.

Original languageEnglish (US)
Pages (from-to)663-672
Number of pages10
JournalBest Practice and Research: Clinical Rheumatology
Volume28
Issue number5
DOIs
StatePublished - 2014

Fingerprint

Inflammatory Bowel Diseases
Reactive Arthritis
Psoriatic Arthritis
Uveitis
HLA Antigens
Natural History
Psoriasis
Arthritis
Spine
Joints
Inflammation
Therapeutics

Keywords

  • Ankylosing spondylitis
  • ASAS classification criteria
  • Axial spondyloarthritis
  • Non-radiographic axial spondyloarthritis

ASJC Scopus subject areas

  • Rheumatology
  • Medicine(all)

Cite this

The concept of spondyloarthritis : Where are we now? / Garg, Neha; Van Den Bosch, Filip; Deodhar, Atulya (Atul).

In: Best Practice and Research: Clinical Rheumatology, Vol. 28, No. 5, 2014, p. 663-672.

Research output: Contribution to journalArticle

@article{86857eee6a0243ef8eb1c1f7f850b29e,
title = "The concept of spondyloarthritis: Where are we now?",
abstract = "The term spondyloarthritis (SpA) encompasses a group of diseases characterized by inflammation in the spine and in the peripheral joints, and other clinical features such as uveitis, dactylitis, psoriasis, inflammatory bowel disease, and association with human leukocyte antigen (HLA) B27. The spectrum of SpA encompasses axial spondyloarthritis (axSpA) and peripheral spondyloarthritis including psoriatic arthritis (PsA), reactive arthritis (ReA), and inflammatory bowel disease-associated arthritis. In recent years, there has been tremendous progress in understanding the natural history and pathogenetic mechanisms underlying SpA leading to the development of effective treatments. It has become imperative to identify the disease early, and accurately, to avail patients of effective treatments in a safe manner. The development of the Assessment of SpondyloArthritis International Society (ASAS) classification criteria has been a welcome advance in this regard. This article provides a historical evolution of the concept of SpA, from the Rome Criteria to the ASAS criteria, current issues and barriers with the use of ASAS criteria, and the work that still needs to be done moving forward.",
keywords = "Ankylosing spondylitis, ASAS classification criteria, Axial spondyloarthritis, Non-radiographic axial spondyloarthritis",
author = "Neha Garg and {Van Den Bosch}, Filip and Deodhar, {Atulya (Atul)}",
year = "2014",
doi = "10.1016/j.berh.2014.10.007",
language = "English (US)",
volume = "28",
pages = "663--672",
journal = "Best Practice and Research in Clinical Rheumatology",
issn = "1521-6942",
publisher = "Bailliere Tindall Ltd",
number = "5",

}

TY - JOUR

T1 - The concept of spondyloarthritis

T2 - Where are we now?

AU - Garg, Neha

AU - Van Den Bosch, Filip

AU - Deodhar, Atulya (Atul)

PY - 2014

Y1 - 2014

N2 - The term spondyloarthritis (SpA) encompasses a group of diseases characterized by inflammation in the spine and in the peripheral joints, and other clinical features such as uveitis, dactylitis, psoriasis, inflammatory bowel disease, and association with human leukocyte antigen (HLA) B27. The spectrum of SpA encompasses axial spondyloarthritis (axSpA) and peripheral spondyloarthritis including psoriatic arthritis (PsA), reactive arthritis (ReA), and inflammatory bowel disease-associated arthritis. In recent years, there has been tremendous progress in understanding the natural history and pathogenetic mechanisms underlying SpA leading to the development of effective treatments. It has become imperative to identify the disease early, and accurately, to avail patients of effective treatments in a safe manner. The development of the Assessment of SpondyloArthritis International Society (ASAS) classification criteria has been a welcome advance in this regard. This article provides a historical evolution of the concept of SpA, from the Rome Criteria to the ASAS criteria, current issues and barriers with the use of ASAS criteria, and the work that still needs to be done moving forward.

AB - The term spondyloarthritis (SpA) encompasses a group of diseases characterized by inflammation in the spine and in the peripheral joints, and other clinical features such as uveitis, dactylitis, psoriasis, inflammatory bowel disease, and association with human leukocyte antigen (HLA) B27. The spectrum of SpA encompasses axial spondyloarthritis (axSpA) and peripheral spondyloarthritis including psoriatic arthritis (PsA), reactive arthritis (ReA), and inflammatory bowel disease-associated arthritis. In recent years, there has been tremendous progress in understanding the natural history and pathogenetic mechanisms underlying SpA leading to the development of effective treatments. It has become imperative to identify the disease early, and accurately, to avail patients of effective treatments in a safe manner. The development of the Assessment of SpondyloArthritis International Society (ASAS) classification criteria has been a welcome advance in this regard. This article provides a historical evolution of the concept of SpA, from the Rome Criteria to the ASAS criteria, current issues and barriers with the use of ASAS criteria, and the work that still needs to be done moving forward.

KW - Ankylosing spondylitis

KW - ASAS classification criteria

KW - Axial spondyloarthritis

KW - Non-radiographic axial spondyloarthritis

UR - http://www.scopus.com/inward/record.url?scp=84927947266&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84927947266&partnerID=8YFLogxK

U2 - 10.1016/j.berh.2014.10.007

DO - 10.1016/j.berh.2014.10.007

M3 - Article

C2 - 25488776

AN - SCOPUS:84927947266

VL - 28

SP - 663

EP - 672

JO - Best Practice and Research in Clinical Rheumatology

JF - Best Practice and Research in Clinical Rheumatology

SN - 1521-6942

IS - 5

ER -